Unique ID issued by UMIN | UMIN000024236 |
---|---|
Receipt number | R000027874 |
Scientific Title | Examination study of the gastroesophageal reflux disease improvement effect by Vonoprazan to the patients with systemic sclerosis |
Date of disclosure of the study information | 2016/10/08 |
Last modified on | 2021/10/07 01:04:38 |
Examination study of the gastroesophageal reflux disease improvement effect by Vonoprazan to the patients with systemic sclerosis
Effect of Vonoprazan to gastroesophageal reflux disease with systemic sclerosis
Examination study of the gastroesophageal reflux disease improvement effect by Vonoprazan to the patients with systemic sclerosis
Effect of Vonoprazan to gastroesophageal reflux disease with systemic sclerosis
Japan |
Gastroesophageal reflux disease
Gastroenterology | Clinical immunology |
Others
NO
To investigate the efficacy and safety of Vonoprazan which is proton pump inhibitor, to patients who suffered from gastroesophageal reflux disease with Systemic sclerosis.
Safety,Efficacy
Exploratory
Levels of IL-8 from tissue of esophageal mucosa taken by biopsy
Symptoms use of F-scale, pH-monitoring, Grade of reflux disease according to Los-Angeles classification, Esophageal manometry, Background, Safety
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Administration 20mg of Vonoprazanone for one year
20 | years-old | <= |
90 | years-old | > |
Male and Female
1. Over 20 years old, and less than 90 years old.
2. Both of male and female
3. It doesn't no matter with hospitalization or outpatient.
4. Diagnosed accompanied with reflux disease of the newcomer patient, and uncontrolled patient by existing proton pump inhibitor.
5. The patient who have understanding of this study, and obtained written consent by own will.
1. Liver and kidney dysfunction
2. Allergy to many kind of drugs.
3. Pregnant or who have a possibility to pregnancy, and under nursing patient.
4. Participation to other study in 4 months.
5. The study patient who decided to inadequacy by person in charge.
6. Administration of atazanavir sulfate and rilpivirin hydrochloryde.
7. Severe allergy or complication history of vonoprazan.
20
1st name | Kazuhiko |
Middle name | |
Last name | Nakao |
Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki University Hospital, Nagasaki, Japan
Department of Gastroenterology and Hepatology
852-8501
Nagasaki University Graduate School of Biomedical Science 1-7-1 Sakamoto, Nagasaki city, Japan, 852-8501
095-819-7481
kazuhiko@nagasaki-u.ac.jp
1st name | Maiko |
Middle name | |
Last name | Tabuchi |
Nagasaki University Hospital
Department of Gastroenterology
852-8501
Nagasaki University Graduate School of Biomedical Science 1-7-1 Sakamoto, Nagasaki city, Japan, 852
095-819-7481
rururu_rarara_my_b_f_ar@yahoo.co.jp
Department of Gastroenterology
Nagasaki University Hospital
Self funding
Self funding
Clinical Research Center, Nagasaki university hospital
Nagasaki University Graduate School of Biomedical Science 1-7-1 Sakamoto, Nagasaki city, Japan, 852-8501
095-819-7726
rinshou7726@umin.ac.jp
NO
長崎大学病院(長崎県)
2016 | Year | 10 | Month | 08 | Day |
Unpublished
Main results already published
2016 | Year | 06 | Month | 28 | Day |
2016 | Year | 06 | Month | 28 | Day |
2016 | Year | 06 | Month | 28 | Day |
2018 | Year | 06 | Month | 28 | Day |
2016 | Year | 09 | Month | 30 | Day |
2021 | Year | 10 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027874
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |